Egile-bilaketaren emaitzak

1

Lanean...

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

nork D. V. Nebieridze
Argitaratua 2016-01-01

Testu osoa

Artigo

2

Lanean...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

nork D. V. Nebieridze
Argitaratua 2015-12-01

Testu osoa

Artigo

3

Lanean...

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

nork D. V. Nebieridze
Argitaratua 2015-12-01

Testu osoa

Artigo

4

Lanean...

Hyperuricemia a New Cardiovascular Risk Factor

nork D. V. Nebieridze
Argitaratua 2020-03-01

Testu osoa

Artigo

5

Lanean...

Topical issues of beta-blockers use in various clinical situations

nork D. V. Nebieridze
Argitaratua 2018-07-01

Testu osoa

Artigo

6

Lanean...

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

nork D. V. Nebieridze
Argitaratua 2002-02-01

Testu osoa

Artigo

7

Lanean...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

nork D. V. Nebieridze
Argitaratua 2015-12-01

Testu osoa

Artigo

8

Lanean...

Topical questions of beta-blockers application in clinical practice

nork D V Nebieridze
Argitaratua 2014-12-01

Testu osoa

Artigo

9

Lanean...

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

nork D. V. Nebieridze, A. S. Safarian
Argitaratua 2016-01-01

Testu osoa

Artigo

10

Lanean...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

nork D. V. Nebieridze, T. V. Kamyshova
Argitaratua 2015-12-01

Testu osoa

Artigo

11

Lanean...

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

nork A. S. Safaryan, D. V. Nebieridze
Argitaratua 2021-10-01

Testu osoa

Artigo

12

Lanean...

New potential of ACE inhibitors in clinical practice

nork D. V. Nebieridze, A. S. Safaryan
Argitaratua 2010-10-01

Testu osoa

Artigo

13

Lanean...

High-risk patients: modern treatment strategy

nork D. V. Nebieridze, A. Meliya
Argitaratua 2010-12-01

Testu osoa

Artigo

14

Lanean...

Place of imidazoline receptor agonists in the treatment of hypertension

nork D. V. Nebieridze, A. S. Safaryan
Argitaratua 2022-01-01

Testu osoa

Artigo

15

Lanean...

Imidazoline receptor agonists: more than blood pressure reduction?

nork D. V. Nebieridze, S. V. Nedogoda
Argitaratua 2006-04-01

Testu osoa

Artigo

16

Lanean...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

nork D. V. Nebieridze, T. V. Kamyshova
Argitaratua 2015-12-01

Testu osoa

Artigo

17

Lanean...

PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE

nork D. V. Nebieridze, N. V. Dolgushina
Argitaratua 2017-12-01

Testu osoa

Artigo

18

Lanean...

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

nork A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
Argitaratua 2020-07-01

Testu osoa

Artigo

19

Lanean...

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?

nork A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
Argitaratua 2017-11-01

Testu osoa

Artigo

20

Lanean...

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

nork N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
Argitaratua 2019-01-01

Testu osoa

Artigo

Emaitzak murriztu